ArticleInternational journal of nanomedicine2026
Near-Infrared Fluorescent Highly Branched Poly(β-Amino Ester)s Nanoparticles for Gene Delivery: In vivo Biodistribution and Safety Evaluation.
Article in International journal of nanomedicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Cationic highly branched poly(β-amino ester)s (HPAEs) represent a promising class of nonviral gene-delivery polymers; however, their in vivo distribution and biological fate remain challenging to monitor. Here, we explored covalent conjugation of indocyanine green (ICG) as a strategy to impart near-infrared-I (NIR-I) fluorescence to HPAEs while maintaining their DNA complexation capacity and gene-delivery performance. Methods: HPAE was modified with increasing feed amounts of ICG-N-hydroxysuccinimide (ICG-NHS), generating a series of fluorescent polymers designated HPAE-0, HPAE-1, HPAE-3, HPAE-5, HPAE-7, and HPAE-9, where the numerical suffixes indicate ICG-NHS feed volumes rather than substitution ratios. The resulting conjugates and their DNA nanoparticles were characterized by spectroscopic and chromatographic analyses, DNA-binding assays, dynamic light scattering, zeta-potential measurements, transmission electron microscopy, and optical-stability evaluation. In vitro gene-delivery activity and cytocompatibility were assessed in multiple cell models, while systemic distribution, biocompatibility, and tissue responses were evaluated in healthy BALB/c mice following administration. Results: Increasing ICG-NHS feed resulted in tunable incorporation of fluorescent moieties into the HPAE backbone. Among the tested formulations, HPAE-3 exhibited an apparent amine substitution degree of 18.98% ± 0.54% and a fluorescence emission maximum at approximately 834 nm. HPAE-3-based nanoparticles displayed favorable physicochemical properties, including hydrodynamic diameters of approximately 170-290 nm, low-to-moderate dispersity (PDI, 0.18-0.40), positive surface potentials (+23 to +40 mV), and efficient DNA condensation at polymer/DNA ratios ≥20:1. Importantly, ICG incorporation at this level preserved reporter-gene expression in HEK293T, RAW264.7, and MLE-12 cells while maintaining acceptable cytocompatibility. Following systemic administration in mice, HPAE-3 mediated luciferase reporter-gene expression predominantly in the liver, spleen, and lungs. HPAE-3-associated NIR-I fluorescence was most evident in the liver and lungs at 6 h, with a weaker signal in the spleen, and declined thereafter; by 72 h, residual ex vivo fluorescence was detected predominantly in the liver. No apparent acute tissue damage, significant alterations in serum biochemical parameters, or deviations in body-weight profiles were observed compared with control groups. Conclusion: HPAE-3 achieved a balanced integration of NIR-I fluorescence, DNA-delivery capability, nanoparticle stability, and preliminary in vivo tolerability. These results establish ICG-labeled HPAE as a potential platform for noninvasive visualization of polymer-mediated gene delivery and provide a foundation for further investigation of its biodistribution, intracellular fate, and therapeutic applications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.